GT Biopharma Inc (GTBP)

[236T568]

GTBP Director & CFO ABRUPTLY resigns from GTBP

https://www.sec.gov/Archives/edgar/data/109657/000165495418011231/gtbp_8k.htm

TEM 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

On October 11, 2018, Steven Weldon resigned from the Board. Mr. Weldon also resigned from his position as Chief Financial Officer at GT Biopharma. This resignation was also effective as of October 11, 2018. Neither resignation involved any disagreement with the Company.




SIGNATURE PAGE

Pursuant to the requirement of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


GT Biopharma, Inc.






Dated: October 16, 2018

By:
/s/Raymond W Urbanski




Raymond W. Urbanski




Chairman and Chief Executive Officer